TROP2‐Targeting Chimeras (TRTACs) for Tumor Cell‐Selective Membrane Protein Degradation and Enhanced Drug Delivery

Luping Chen, Xinying Fu, Wenqian Dong, Xiaobei Deng, Simin Chen, Fujun Wang, Jian Zhao, Shiqun Shao, Liqiang Fan, Jingyu Zhang, Lixin Zhang · 2026

Read TROP2‐Targeting Chimeras (TRTACs) for Tumor Cell‐Selective Membrane Protein Degradation and Enhanced Drug Delivery by Luping Chen, Xinying Fu, Wenqian Dong, Xiaobei Deng, Simin Chen, Fujun Wang, Jian Zhao, Shiqun Shao, Liqiang Fan, Jingyu Zhang, Lixin Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13616387.txt.

Description

Luping Chen and colleagues build tumour-targeting chimeras that drag cancer cell surface proteins into the cell's disposal system, using a marker called TROP2 as the handle. TROP2 sits thickly on many tumour cells and already serves as the target of approved antibody-drug pairs. Their chimera fuses a TROP2-gripping nanobody, a tiny antibody fragment, to a second nanobody aimed at the protein to be destroyed, all in one small, fully gene-encoded piece of about 30 kilodaltons.

The chimeras forced the breakdown of several major cancer proteins, including two growth receptors and the immune brake PD-L1, preferring tumour cells over healthy ones. The small format should slip deeper into tumours than bulky antibodies. Turning a proven cancer address into a general delivery route for protein destruction widens a young drug strategy considerably.

Catalog record

CREATORLuping Chen, Xinying Fu, Wenqian Dong, Xiaobei Deng, Simin Chen, Fujun Wang, Jian Zhao, Shiqun Shao, Liqiang Fan, Jingyu Zhang, Lixin Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13616387

Browse the full library · About the Tower of Babel